This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: L. Molteni & C. Dei Fratelli Alitti, L. Molteni & C. Dei Fratelli Alitti—società Di Esercizio S.p.a.. Active years: 2007-2012.
Company Filing History:
2 out of 2 
2 out of 7 Years Active: 2007-2012
Title: Francesca Giuntini: Innovator in Photodynamic Therapy
Introduction
Francesca Giuntini, based in Mercatale Val Di Pesa, Italy, is a notable inventor recognized for her significant contributions to the field of photodynamic therapy. With a total of four patents to her name, Giuntini has made strides in the development of innovative solutions for medical applications.
Latest Patents
Among her recent inventions, Giuntini has focused on Meso-substituted porphyrins, described as compounds suitable for use as photosensitizing agents in photodynamic therapy. Her patented formulations of Meso-substituted porphyrins hold promise for advancements in cancer treatment, marking a vital progression in therapeutic technologies.
Career Highlights
Giuntini's career includes valuable experience with renowned companies like L. Molteni & C. Dei Fratelli Alitti and L. Molteni & C. Dei Fratelli Alitti Società di Esercizio S.p.a. Her innovative work has positioned her as a leader in her domain, earning recognition for her commitment to research and development.
Collaborations
During her professional journey, Francesca collaborated with esteemed colleagues, including Gabrio Roncucci and Donata Dei. These collaborations have not only enhanced her research efforts but have also fostered an environment of innovation and shared knowledge within her field.
Conclusion
Francesca Giuntini's contributions to the realm of photodynamic therapy through her patents and collaborative efforts exemplify the impact of innovation in medical science. Her continued dedication to research continues to inspire advancements that may change the landscape of treatment options available to patients in the future.